EURONEXT-PAR$NBTX

Nanobiotix SA · Q2 2011 earnings

Q2 2011 earnings · · Investor relations

Headline financials

Total Revenue

€680K

No prior period
EPS (adj)

-€1.71

No prior period
Net Income

-€2.62M

No prior period
Operating Income

-€2.61M

No prior period
Gross Profit

€680K

No prior period
R&D Expense

€2.61M

No prior period

Revenue & EPS history

Nanobiotix SA · Revenue · Quarterly

€680K

Q2 2011

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 8 quarterly earnings reports

Historical avg

-2.5%

Avg return

Earnings day

-8.7%

Avg return

5 days after

+9.1%

Avg return

30 days after

63%

5 / 8 earnings

Positive

+6.4%

Q2 2024

Best reaction

-31.3%

Q4 2022

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026———
Q2 2024+6.4%-1.4%-5.4%
Q4 2024+3.5%+1.8%+15.6%
Q2 2023-1.5%-4.2%+48.6%
Q4 2022-31.3%-42.8%+33.4%
Q2 2022-5.9%-4.6%+7.0%
Q4 2021+3.8%-5.7%-15.5%
Q2 2021+0.8%-3.8%+3.2%
Q4 2020+4.6%-9.2%-14.2%
Q2 2020———
Q4 2019———
Q2 2019———
Q4 2018———
Q2 2018———
Q4 2017———
Q2 2017———
Q4 2016———
Q2 2016———
Q4 2015———
Q2 2015———
Q4 2014———
Q2 2014———
Q4 2013———
Q2 2013———
Q4 2012———
Q4 2011———
Q2 2011———

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro